mTOR complexes in neurodevelopmental and neuropsychiatric disorders

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Signaling

Background:

• The mechanistic target of rapamycin (mTOR) is a central signaling hub integrating neuronal activity and synaptic inputs.
• mTOR exists in two complexes, mTORC1 and mTORC2, critical for synaptic plasticity and memory.
• Aberrant mTOR signaling is implicated in neurodevelopmental and neuropsychiatric disorders.

Purpose of the Study:

• To review recent advancements in understanding mTOR signaling in the brain.
• To explore the mechanisms by which mTOR complexes influence neurological diseases.
• To discuss the clinical significance of mTOR pathway research in neurology.

Main Methods:

• Literature review of recent studies on mTOR signaling in the brain.
• Analysis of research on mTOR complex function in neurological disease models.
• Synthesis of findings related to the medical relevance of mTOR in neurological disorders.

Main Results:

• Recent studies reveal intricate roles of mTORC1 and mTORC2 in neuronal function and synaptic plasticity.
• Evidence links mTOR pathway dysregulation to the pathophysiology of various neurological conditions.
• Specific mechanisms of mTOR involvement in diseases like autism spectrum disorder and Alzheimer's disease are being elucidated.

Conclusions:

• mTOR signaling is a crucial regulator of brain function with significant implications for neurological health.
• Targeting mTOR pathways presents potential therapeutic strategies for treating neurological diseases.
• Further research into mTOR complex function can advance our understanding and treatment of brain disorders.